Skip to main content
KLRS logo

KLRS · Kalaris Therapeutics, Inc. · Debt

Track KLRS — free
$3.38 +0.08 (+2.42%) At close · Sep 11
Market Cap
$80.46M
Shares
23.80M

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.
Key facts CIK 1754068 CUSIP 482929106 13F (30d) 23 filings 23 filers Visit website Investor relations